Vimarsana
Biggest News Aggregation in the World

Page 37 - Simon Vincent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simon Vincent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simon Vincent Today - Breaking & Trending Today

Cancer patients less protected after first COVID vaccine jab, UK study finds - Vimarsana News

Cancer patients less protected after first COVID vaccine jab, UK study finds

Cancer patients less protected after first COVID vaccine jab, UK study finds Cancer patients are much less protected against Covid-19 than other people after one dose of the Pfizer vaccine, the first real-world study in this area suggests. Share Via Email   |  A+A A- By PTI LONDON: Cancer patients may not be protected to the same degree as the rest of the population after they receive their first of two doses of a COVID-19 vaccine, a new UK study has found on Thursday. A team of experts from King's College London and Francis Crick Institute found in the first real-world study of its k...

Covid: Single dose of Pfizer vaccine does not adequately protect cancer patients against coronavirus, researchers say - Vimarsana News

Covid: Single dose of Pfizer vaccine does not adequately protect cancer patients against coronavirus, researchers say

Researchers are calling for the government to urgently review its plan to delay the second dose of the vaccine.

Source: itv.com
One dose of Pfizer jab gives inadequate protection to cancer sufferers, study shows - Vimarsana News

One dose of Pfizer jab gives inadequate protection to cancer sufferers, study shows

Scientists have called for an urgent review after a study found a 12-week gap between doses left cancer patients vulnerable to serious Covid

HALF of cancer patients 'are not protected against Covid after one dose of Pfizer's vaccine' - Vimarsana News

HALF of cancer patients 'are not protected against Covid after one dose of Pfizer's vaccine'

More than half of cancer patients may not be protected against coronavirus after a single dose of the Pfizer vaccine, an alarming study has claimed.  Research of more than 150 patients found the jab stimulated an antibody response in just 39 per cent of people with solid cancers, such as in the breast or prostate, after three weeks. The single dose was even less effective in blood and bone marrow cancer patients, with just 13 per cent developing the virus-fighting proteins, compared to 97 per cent of healthy people.    The King's College London study found that when patients were given th...

Cancer patients less protected after first Covid vaccine jab, UK study finds | India News - Vimarsana News

Cancer patients less protected after first Covid vaccine jab, UK study finds | India News

India News: LONDON: Cancer patients may not be protected to the same degree as the rest of the population after they receive their first of two doses of a Covid-1.